Heterocyclic tautomerism: Reassignment of two crystal structures of 2-amino-1,3-thia-zolidin-4-one derivatives

Acta Crystallographica Section C: Structural Chemistry

Volumn 70, Issue 8, 2014, Pages 812-816

  Gzella, Andrzej K ^a   Kowiel, Marcin ^a   Suseł, Aneta ^a   Wojtyra, Magdalena N ^b   Lesyk, Roman ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

2 amino(imino) 1,3 thiazolidin 4 ones; amine imine tautomerism; biologically active compounds; crystal structure; heterocyclic tautomerism; hydrogen bonding; medicinal chemistry; pharmaceutical compounds

Indexed keywords

ATOMS; BIOACTIVITY; CARBONYL COMPOUNDS; COMPLEXATION; CRYSTAL ATOMIC STRUCTURE; CRYSTAL STRUCTURE; NITROGEN COMPOUNDS; STEREOCHEMISTRY;

2-AMINO(IMINO)-1,3-THIAZOLIDIN-4-ONES; AMINE-IMINE TAUTOMERISM; BIOLOGICALLY ACTIVE COMPOUNDS; HETEROCYCLIC TAUTOMERISM; MEDICINAL CHEMISTRY; PHARMACEUTICAL COMPOUNDS;

HYDROGEN BONDS;

2 AMINO 1,3 THIAZOLIDIN 4 ONE; 2-AMINO-1,3-THIAZOLIDIN-4-ONE; 5 (2 HYDROXYETHYL) 2 ((PYRIDIN 2 YL)AMINO) 1,3 THIAZOLIDIN 4 ONE; 5-(2-HYDROXYETHYL)-2-((PYRIDIN-2-YL)AMINO)-1,3-THIAZOLIDIN-4-ONE; AMINOBENZOIC ACID DERIVATIVE; ETHYL 4 ((4 OXO 1,3 THIAZOLIDIN 2 YL)AMINO)BENZOATE; ETHYL 4-((4-OXO-1,3-THIAZOLIDIN-2-YL)AMINO)BENZOATE; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE; THIAZOLIDINE DERIVATIVE;

2-AMINO(IMINO)-1,3-THIAZOLIDIN-4-ONES; AMINE-IMINE TAUTOMERISM; ARTICLE; BIOLOGICALLY ACTIVE COMPOUNDS; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTAL STRUCTURE; HETEROCYCLIC TAUTOMERISM; HYDROGEN BOND; MEDICINAL CHEMISTRY; PHARMACEUTICAL COMPOUNDS; X RAY CRYSTALLOGRAPHY;

2-AMINO(IMINO)-1,3-THIAZOLIDIN-4-ONES; AMINE-IMINE TAUTOMERISM; BIOLOGICALLY ACTIVE COMPOUNDS; CRYSTAL STRUCTURE; HETEROCYCLIC TAUTOMERISM; HYDROGEN BONDING; MEDICINAL CHEMISTRY; PHARMACEUTICAL COMPOUNDS;

AMINOBENZOATES; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MOLECULAR STRUCTURE; PYRIDINES; THIAZOLES; THIAZOLIDINES;

EID: 84905445556     PISSN: None     EISSN: 20532296     Source Type: Journal    
DOI: 10.1107/S2053229614015162     Document Type: Article

References (17)

1. Agilent (2010). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, Oxfordshire, England.
2. Agilent (2012). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, Oxfordshire, England.
3. Allen, F. H. (2002). Acta Cryst. B58, 380-388.
4. Allen, F. H., Kennard, O.,Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
5. Behbehani, H. & Ibrahim, H. M. (2012). Molecules, 17, 6362-6385.
6. Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
7. Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
8. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339-341.
9. Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
10. Geronikaki, A., Eleftheriou, P., Vicini, P., Alam, I., Dixit, A. & Saxena, A. K. (2008). J. Med. Chem. 51, 5221-5228.
11. Lesyk, R. B. & Zimenkovsky, B. S. (2004). Curr. Org. Chem. 8, 1547-1577.
12. Lesyk, R. B., Zimenkovsky, B. S., Kaminskyy, D. V., Kryshchyshyn, A. P., Havrylyuk, D. Ya., Atamanyuk, D. V., Subtel'na, I. Yu. & Khyluk, D. V. (2011). Biopolym. Cell, 27, 107-117.
13. Ostapiuk, Y. V., Obushak, M. D., Matiychuk, V. S., Naskrent, M. & Gzella, A. K. (2012). Tetrahedron Lett. 53, 543-545.
14. Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
15. Spek, A. L. (2009). Acta Cryst. D65, 148-155.
16. Subtel'na, I., Atamanyuk, D., Szymanska, E., Kieć-Kononowicz, K., Zimenkovsky, B., Vasylenko, O., Gzella, A. & Lesyk, R. (2010). Bioorg. Med. Chem. 18, 5090-5102.
17. Váňa, J., Hanusek, J., Růžička, A. & Sedlák, M. (2009). J. Heterocycl. Chem. 46, 635-639.